In context
Melanotan II was investigated in a zebrafish model involving a high-fat diet and behavioural testing. [1]
At a glance
- Type
- Peptide / related experimental research
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- Fish behaviour does not establish human cognitive benefit or the safety of tanning products. Melanotan II should not be confused with afamelanotide's product-specific medical indication.
How to interpret this evidence
Fish behaviour does not establish human cognitive benefit or the safety of tanning products. Melanotan II should not be confused with afamelanotide's product-specific medical indication. [1]
Safety and clinical context
The evidence described here does not establish safety for unsupervised use. Product identity, route, formulation, interactions and long-term effects cannot be inferred from a study category.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.
- Melanotan-II reverses memory impairment induced by a short-term HF diet. pubmed.ncbi.nlm.nih.gov